A study to assess the plaque inhibitory action of a new zinc citrate toothpaste formulation

Citation
J. Moran et al., A study to assess the plaque inhibitory action of a new zinc citrate toothpaste formulation, J CLIN PER, 28(2), 2001, pp. 157-161
Citations number
32
Categorie Soggetti
Dentistry/Oral Surgery & Medicine","da verificare
Journal title
JOURNAL OF CLINICAL PERIODONTOLOGY
ISSN journal
03036979 → ACNP
Volume
28
Issue
2
Year of publication
2001
Pages
157 - 161
Database
ISI
SICI code
0303-6979(200102)28:2<157:ASTATP>2.0.ZU;2-G
Abstract
Background, aims: Zinc-citrate-containing toothpastes have previously been suggested to be of value at inhibiting plaque and gingival inflammation. Pr esent formulations have included triclosan which is thought to contribute m ajor antibacterial/antiplaque effects. Alternative antimicrobial agents and other ingredients such as oils could help to produce equally effective for mulations. The aim of this study was to determine whether zinc citrate toot hpastes containing bromochlorophene and a triglyceride oil (1% and 8%) coul d inhibit de novo plaque formation. Methods: Toothpaste slurry rinses were used over a 96-h period by 24 volunt eers, whilst omitting all other oral hygiene procedures. For comparative pu rposes, a conventional commercial fluoride control toothpaste was also used in this triple cross-over double blind study. Results: After 24 and 48 h, there were no statistically significant differe nces in plaque between the 2 test pastes and the control paste, whether ass essed using a plaque index or plaque area. After 96 h, however, a significa nt reduction in plaque score of 10.6% and 24.2% in plaque area (both p<0.00 1) was found for the zinc citrate/1% oil toothpaste compared to the control paste. In addition, at 96 h, the 8% oil toothpaste significantly reduced p laque score compared to the control paste by 4.3% (p=0.029). Conclusions: These findings would appear to warrant further investigation i nto the potential value of the zinc citrate/bromochlorophene/triglyceride f ormulation at inhibiting both plaque and gingival inflammation.